Salary: Commencement on the salary range is subject to comparable skills and experience. Future progression is based on annual performance review.
Duration of Contract: 12 months to start with
Hours per week: 35 hours per week (Full Time)
Summary of Role
The Institute of Cancer Research is looking for a Clinical Data Analyst to work in the Investigator Initiated Trials (IIT) Team, which is part of the Drug Development Unit (DDU). The DDU-IIT team run a diverse portfolio of phase I multicentre trials of targeted treatments and combination.
The post offers an excellent opportunity for an enthusiastic and well-motivated individual to work in a motivated and supportive academic team that are at the forefront of Phase-I cancer trials.
The successful applicant will work with Trial Managers, Clinical Research Associates, Statisticians and Clinical Trial Assistants and duties will include:
- managing the data collected during a clinical trial;
- help designing the database used to collect the data;
- reviewing the data that is collected;
- analysing the data by creating data tables for reports and publications
- supporting Senior Clinical Data Analyst in overseeing data management activities of the IIT team
We are looking for an individual with a passion for data and enthusiasm to fit into a forward thinking Phase I team, working on novel approaches to cancer treatments. The successful candidate must be educated to a degree level in life science or nursing. They should have excellent attention to detail, interpersonal skills and the ability to prioritise and manage workload as an essential skill. It is also desirable that the applicant has knowledge of clinical trials or oncology, data management and/or databases and has an understanding of ICH-GCP (Directive 2001/20/EC and 2005/28/EC).
Drug Development Unit – Investigator Initiated Trials team
The Drug Development Unit, led by Professor Johann de Bono aims to seamlessly integrate preclinical drug discovery, proof-of-principle phase I trials and tumour-specific evaluation of novel agents. It is a conduit for the two-way communication between laboratory and clinical teams that is so essential for successful modern drug development. The unit conducts first-in-man phase I trials involving a range of targets, including growth factor or intracellular signalling, angiogenesis, apoptosis, epigenetics and DNA repair. All trials are underpinned by extensive analysis of biomarkers, both predictive and pharmacodynamics. The DDU includes The Oak Foundation Drug Development Centre (Oak Ward) housed within The Royal Marsden at the Sutton site and specifically designed for phase I clinical trials. Opened in February 2005, the centre provides 10 inpatient beds, five treatment chairs and two outpatient suites, and allows researchers to enter almost 300 patients onto phase I trials each year. This makes the unit one of the largest of its kind in the world.
When applying please provide a supporting statement detailing why you are applying for this position and detailing your relevant experience; together with your CV including details of your current salary and the names and addresses of two referees.
We encourage all applicants to access the job pack attached for more detailed information regarding this role.
For an informal discussion regarding the role, please contact Toby Prout via Email on email@example.com